Anna Thor from SWENOTECA awarded grant to improve care for men with testicular cancer At the annual meeting of the Swedish Association for Urological Oncology (SFUO) in Stockholm on 13 November 2025, researcher Anna Thor from Karolinska Institutet received a SEK 100,000 grant — awarded in collaboration with pharmaceutical company Pfizer — for her work on metastatic testicular cancer.  Her project investigates whether surgery can replace chemotherapy for some men with dissemin

Dear friends. Next years annual meeting will take place Thursday, April 16th, 2026 at Oslo Airport Gardermoen. Detailed program will follow.

Thursday, February 6th, this year's annual meeting was arranged at the new Karolinska Hospital, Solna in Stockholm. We would like to...

A revision of the SWENOTECA X protocol and new patients information have now been published. The main change is regarding stage I...

We are delighted to welcome all SWENOTECA friend to this years annual meeting in Stockholm, Thursday, February 6th, 2025. Enclosed is the...

Dear friends, the next annual meeting will take place in Stockholm on Thursday, February 6th, 2025. Detailed invitations and program will...

The ABC-study has now fully included. From April 25th we close the study for inclusion. A great thanks to all patiebts and personell...

Today a update on SWENOTECA X is published online. There are changes to follow-up of seminoma and metastatic nonseminoma. Changes can be...

We would like to thank all participants and speakers at the at the annual meeting in Stockholm. The protocol from the the meeting can be...

Dear SWENOTECA friends. It is finally time for the annual meeting. The meeting will be arranged in Stockholm, at Scandic HayMarket...